In this study, CD37 has been discovered to interact with suppressor of cytokine signaling 3 (SOCS3), and its absence was hypothesized to drive lymphoma development through constitutive activation of the IL-6 signaling pathway (Figure 1). The gene discussed is SOCS3; the disease is lymphoma.